title: [Inhibition of post-partum physiological milk secretion by caffeine dihydroergocryptine and dihydroergotoxine].
abstract: Starting from the structural analogy between bromo-ergocryptine (Parlodel) and dihydroergocryptine caffeine (Vasobral), as well as with dihydroergotoxine (Hydergine), the authors decided to test the efficacy of the last two products in inhibiting post-partum physiological milk secretion. Twelve patients will be treated with either one of the two products, with a clinical and biological efficacy (serum prolactin level assay) which is comparable to that found in the literature regarding Parlodel. This study confirm the results obtained in a study of the inhibition of hyper-prolactinemia of other origin, by the same authors.
authors.affiliation: Clinique Mutualiste des Eaux Claires de Grenoble.
authors.forename: M
authors.initials: M
authors.lastname: Elsener
authors.forename: M
authors.initials: M
authors.lastname: Ferrafiat
authors.forename: M
authors.initials: M
authors.lastname: de Bruyn
authors.forename: P
authors.initials: P
authors.lastname: Jouhet
authors.forename: Y
authors.initials: Y
authors.lastname: Robert
authors.forename: P E
authors.initials: PE
authors.lastname: Rouge
mesh_terms: D000328:Adult; D001940:Breast / Q000473:pathology; D004088:Dihydroergotoxine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects*; D049590:Postpartum Period; D011247:Pregnancy; D011388:Prolactin / Q000097:blood
chemical_list: D004088:Dihydroergotoxine; D011388:Prolactin
vernacular_title: Inhibition de la sécrétion lactée physiologique du post-partum par la dihydro-ergokryptine caféine et la dihydro-ergotoxine.